What’s new at CRO

Read all News
Date
Jun 13, 2024

White Paper | Therapeutic Concepts for Obesity and Related Diseases inc. HFpEF - Part 3

Teaser text
In Part 3, the diverse phenotypes of heart failure (HF) will be discussed with a special focus on the cardiometabolic HF phenotype with preserved ejection fraction (HFpEF). The pathophysiology ...
Read more
Date
Apr 26, 2024

White Paper | Therapeutic Concepts for Obesity and Related Diseases inc. NAFLD/NASH - Part 2

Teaser text
In Part 2 the current pharmacological approaches for the treatment of NAFLD/NASH with or without obesity will be presented and discussed based on current research and applicable guidelines ...
Read more
Date
Mar 26, 2024

White Paper | Therapeutic Concepts for Obesity and Related Diseases inc. Type-2 Diabetes Mellitus - Part 1

Teaser text
The CRO has written a Whitepaper based on our experience in the conduct of early phase projects for new anti-obesity drugs. We want to share our expertise in this special Whitepaper ...
Read more